Bannantine John P, Campo Joseph J, Li Lingling, Randall Arlo, Pablo Jozelyn, Praul Craig A, Raygoza Garay Juan Antonio, Stabel Judith R, Kapur Vivek
U.S. Department of Agriculture, Agricultural Research Service, National Animal Disease Center, Ames, Iowa, USA
Antigen Discovery, Inc., Irvine, California, USA.
Clin Vaccine Immunol. 2017 Jul 5;24(7). doi: 10.1128/CVI.00081-17. Print 2017 Jul.
Johne's disease, a chronic gastrointestinal inflammatory disease caused by subspecies , is endemic in dairy cattle and other ruminants worldwide and remains a challenge to diagnose using traditional serological methods. Given the close phylogenetic relationship between subsp. and the human pathogen , here, we applied a whole-proteome protein array to identify seroreactive and diagnostic subsp. antigens. A genome-scale pairwise analysis of amino acid identity levels between orthologous proteins in subsp. and showed an average of 62% identity, with more than half the orthologous proteins sharing >75% identity. Analysis of the protein array probed with sera from subsp. -infected cattle showed antibody binding to 729 proteins, with 58% of them having ≥70% identity to subsp. orthologs. The results showed that only 4 of the top 40 seroreactive antigens were orthologs of previously reported subsp. antigens, revealing the existence of a large number of previously unrecognized candidate diagnostic antigens. Enzyme-linked immunosorbent assay (ELISA) testing of 20 subsp. recombinant proteins, representing reactive and nonreactive orthologs, further confirmed that the array has utility as a screening tool for identifying candidate antigens for Johne's disease diagnostics. Additional ELISA testing of field serum samples collected from dairy herds around the United States revealed that MAP2942c had the strongest seroreactivity with Johne's disease-positive samples. Collectively, our studies have considerably expanded the number of candidate subsp. proteins with potential utility in the next generation of rationally designed Johne's disease diagnostic assays.
副结核分枝杆菌引起的约内氏病是一种慢性胃肠道炎症性疾病,在全球范围内的奶牛和其他反刍动物中呈地方性流行,使用传统血清学方法进行诊断仍然是一项挑战。鉴于副结核分枝杆菌亚种与人类病原体之间密切的系统发育关系,在此,我们应用全蛋白质组蛋白阵列来鉴定具有血清反应性和诊断性的副结核分枝杆菌亚种抗原。对副结核分枝杆菌亚种和[未提及的物种]直系同源蛋白之间的氨基酸同一性水平进行全基因组规模的成对分析,结果显示平均同一性为62%,超过一半的直系同源蛋白同一性>75%。用副结核分枝杆菌亚种感染牛的血清检测蛋白阵列,结果显示抗体与729种蛋白结合,其中58%与副结核分枝杆菌亚种直系同源蛋白的同一性≥70%。结果表明,在40种血清反应性最强的抗原中,只有4种是先前报道的副结核分枝杆菌亚种抗原的直系同源物,这揭示了存在大量先前未被识别的候选诊断抗原。对代表反应性和非反应性直系同源物的20种副结核分枝杆菌亚种重组蛋白进行酶联免疫吸附测定(ELISA)测试,进一步证实该阵列可作为一种筛选工具,用于鉴定约内氏病诊断的候选抗原。对从美国各地奶牛场采集的现场血清样本进行的额外ELISA测试表明,MAP2942c与约内氏病阳性样本的血清反应性最强。总体而言,我们的研究极大地扩展了具有潜在用途的副结核分枝杆菌亚种蛋白的数量,这些蛋白可用于下一代合理设计的约内氏病诊断检测。